After facing allegations of running a pharmaceutical fraud scheme and later confessing to mail and wire fraud charges in 2020, former pharmacy operator Arkadiy Khaimov is going to prison.
Last week, the U.S. Department of Justice announced that Judge Joan Azrack had sentenced Khaimov to 51 months for his involvement in defrauding an unnamed pharmaceutical manufacturer of almost $7.2 million.
While Khaimov had also been implicated in Gilead’s counterfeiting case, and him and his brother are currently indicted for the charges, neither party has confirmed whether the recent sentencing is a result of these allegations.
Last week's sentencing states that Khaimov established a co-pay coupon program to reimburse pharmacies for dispatching a “priceless breakthrough” treatment for a potentially deadly disease. Then, the conspirators submitted false reimbursement claims from pharmacy computers located in Manhattan and Queens between February 2017 and July 2018 for the medications that had never been dispensed, scheming several million dollars from the company referred to as “John Doe Company 1.”
The DOJ also said that as part of the sentence, Khaimov must forfeit approximately $489,000 as proceeds involved in the fraudulent scheme and to pay restitution of approximately $7.2 million.